½ÃÀ庸°í¼­
»óǰÄÚµå
1552863

¼¼°èÀÇ ÇコÄɾî ERP ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ±â´Éº°, Àü°³º°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Healthcare ERP Market Size, Share & Trends Analysis Report By Function (Inventory & Material Management, Supply Chain & Logistics Management), By Deployment (On-premises, Cloud), By End-use, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 128 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

°Ç°­ °ü¸® ERP ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è °Ç°­ °ü¸® ERP ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 7.2%¸¦ ±â·ÏÇßÀ¸¸ç, 2030³â¿¡´Â 119¾ï 6,000¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù.

ÇコÄɾî Á¶Á÷Àº ÁöÃâ Áõ°¡, ºñÈ¿À²ÀûÀÎ º´¿ø ¼­ºñ½º °ü¸®, ³ëµ¿·Â ºÎÁ·, ȯÀÚ ¼ö Áõ°¡¸¦ ¾ïÁ¦Çϱâ À§ÇØ ±â¼úÀû ¼Ö·ç¼ÇÀ» µµÀÔÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù. ¾çÁúÀÇ ÀÇ·á Á¦°ø ¼Ö·ç¼Ç, ¹é¿£µå ¼öÀÛ¾÷ Á¦°Å, ¿î¿µ °æºñ ÃÖ¼ÒÈ­ µî ERP ½Ã½ºÅÛ µµÀÔ°ú °ü·ÃµÈ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ´Ù´Â °ÍÀÌ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Ŭ¶ó¿ìµå ±â¹Ý ERP ½Ã½ºÅÛÀº °íÀ¯ÀÇ ÀåÁ¡À¸·Î ÀÎÇØ ÀÇ·á Á¦°ø¾÷üµé »çÀÌ¿¡¼­ äÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº È®À强ÀÌ ÀÖÀ¸¹Ç·Î Á¶Á÷Àº Çϵå¿þ¾î¿¡ ¸¹Àº ÅõÀÚ¸¦ ÇÏÁö ¾Ê°íµµ Çʿ信 µû¶ó ¸®¼Ò½º¸¦ Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Å¬¶ó¿ìµå ±â¹Ý ERP ½Ã½ºÅÛÀº ¿ø°Ý ÀÇ·á ¼­ºñ½º ¹× ºÐ»êµÈ ÀÇ·á ¼­ºñ½º¸¦ Áö¿øÇÏ´Â µ¥ ÇʼöÀûÀÎ µ¥ÀÌÅÍ ¹× ¿ëµµ¿¡ ´ëÇÑ ¿ø°Ý ¾×¼¼½º¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ¾×¼¼½º´Â ¿ø°ÝÁö¿¡¼­µµ ¿øÈ°ÇÑ Çù¾÷°ú °ü¸®ÀÇ ¿¬¼Ó¼ºÀ» º¸ÀåÇÕ´Ï´Ù.

ERP ½Ã½ºÅÛÀº ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­Çϰí Áߺ¹¼ºÀ» ÁÙÀÓÀ¸·Î½á ºñÁî´Ï½º È¿À²¼º ¸ñÇ¥¸¦ ´Þ¼ºÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ȯÀÚ °ü¸®, Àç°í °ü¸®, À繫 ¾÷¹« µî ´Ù¾çÇÑ ±â´ÉÀ» ´ÜÀÏ ½Ã½ºÅÛ¿¡ ÅëÇÕÇÔÀ¸·Î½á ERP´Â Áߺ¹ ÀÛ¾÷À» ¾ø¾Ö°í µ¥ÀÌÅÍ Àϰü¼ºÀ» º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ ¹× ºÐ¼®À» Á¦°øÇÔÀ¸·Î½á ¸®¼Ò½º Ȱ¿ëÀ» ÃÖÀûÈ­ÇÏ°í ´õ ³ªÀº ÀÇ»ç °áÁ¤°ú Á÷¿ø ¹× ÀÚÀçÀÇ È¿À²ÀûÀÎ ¹èÆ÷¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¾ÇÕÀûÀÎ Á¢±Ù¹ýÀº ºñ¿ëÀ» Àý°¨ÇÏ°í »ý»ê¼ºÀ» Çâ»ó½ÃŰ°í °á±¹ ȯÀÚ °ü¸®¿Í Á¶Á÷ÀÇ ¼º´ÉÀ» Çâ»ó½Ãŵ´Ï´Ù.

½ÃÀå ±â¾÷Àº ½ÅÁ¦Ç° °³¹ß ¹× ½Å±â¼ú µµÀÔ¿¡ ÁÖ·ÂÇÏ¿© °í°´ÀÇ ERP ½Ã½ºÅÛ µµÀÔ ±â°£À» ´ÜÃàÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 1¿ù, Atrium Health´Â »õ·Ó°Ô °³¹ßÇÑ Premier's ±â¼ú¿¡ ÀÇÇØ ERP µµÀÔ ½Ã°£À» 90% ´ÜÃàÇß½À´Ï´Ù. PremierÀÇ ¾ÆÀÌÅÛ ¸¶½ºÅÍ Å¬¸°½º¿Í PINC AI Content Hub´Â °ø±Þ¸Á µ¥ÀÌÅÍ ÅëÇÕÀ» °£¼ÒÈ­ÇÏ°í ±ú²ýÇϰí Ç¥ÁØÈ­µÈ Á¤º¸¸¦ È®º¸Çß½À´Ï´Ù. ÀÌ È¿À²ÀûÀÎ µ¥ÀÌÅÍ °ü¸®´Â Áö¿¬À» ÃÖ¼ÒÈ­Çϰí, ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀ̰í, Àü¹ÝÀûÀÎ ¾÷¹« È¿À²¼ºÀ» °³¼±Çϸç, ¾ÆÆ®¸®¿ò °Ç°­ÀÌ »õ·Î¿î ERP ½Ã½ºÅÛÀ¸·ÎÀÇ ¼º°øÀûÀÎ Àüȯ, ½Ç½Ã°£ µ¥ÀÌÅÍ ¹× ºÐ¼® Á¦°øÇÔÀ¸·Î½á ÀÚ¿ø Ȱ¿ëÀ» ÃÖÀûÈ­ÇÏ°í ´õ ³ªÀº ÀÇ»ç °áÁ¤°ú Á÷¿ø ¹× ÀÚÀçÀÇ È¿À²ÀûÀÎ ÇÒ´çÀ» °¡´ÉÇÏ°Ô Çß½À´Ï´Ù. ÀÌ·¯ÇÑ Á¾ÇÕÀûÀÎ Á¢±Ù ¹æ½ÄÀº ºñ¿ë Àý°¨°ú »ý»ê¼º Çâ»óÀ» Á¦°øÇϸç, ±Ã±ØÀûÀ¸·Î ȯÀÚ °ü¸® ¹× Á¶Á÷ ¼º´ÉÀ» Çâ»ó½Ãŵ´Ï´Ù.

°Ç°­ °ü¸® ERP ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ±â´É ºÎ¹®º°·Î 2023³â¿¡´Â ÇÁ·±Æ®¿£µå ¼öÀÍÁֱ⠰ü¸® ÇÁ·Î¼¼½º¿Í ¹é¿£µå Ȱµ¿ °£ÀÇ À庮À» ÁÙÀÏ Çʿ伺 ¶§¹®¿¡ À繫¿Í û±¸°¡ ½ÃÀåÀ» µ¶Á¡ÇÕ´Ï´Ù.
  • µµÀÔ ºÐ¾ßº°·Î´Â ¿ÂÇÁ·¹¹Ì½º µµÀÔ ºÐ¾ß°¡ 2023³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î º´¿ø ºÎ¹®Àº 2023³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀÌ ¼ºÀåÀÇ ¹è°æ¿¡´Â ¿¹»ê ÁöÃâÀ» ¾ïÁ¦Çϸ鼭 Á¾ÀÌ ÀÛ¾÷À» ÁÙÀ̰í, È¿°ú¸¦ Çâ»ó½Ã۰í, ȯÀÚ °ü¸®¸¦ °­È­ÇÏ´Â È¿À²ÀûÀΠȯÀÚ ¹× ÀÇ»ç °ü¸® µµ±¸¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
  • ºÏ¹Ì°¡ 2023³â¿¡ ¿ìÀ§¸¦ Â÷ÁöÇÑ °ÍÀº ÀÌ·¯ÇÑ ¼±Áø ±â¼ú ½Ã½ºÅÛÀÇ µµÀÔ ¼öÁØÀÌ »ó½ÂÇÏ°í ½ÃÀå ±â¾÷ÀÇ Á¸Àç°¨ÀÌ Å©±â ¶§¹®ÀÔ´Ï´Ù. °Ô´Ù°¡ ¾Æ½Ã¾ÆÅÂÆò¾çÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)ÀÌ 8.6%·Î °¡Àå À̸¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÇコÄɾî ERP ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå °ßÀÎ ¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • °Ç°­ °ü¸® ERP ½ÃÀå ºÐ¼® µµ±¸
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®
    • »ç·Ê ¿¬±¸
    • COVID-19ÀÇ ¿µÇâ

Á¦4Àå ÇコÄɾî ERP ½ÃÀå : ±â´Éº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ±â´É ½ÃÀå Á¡À¯À², 2023³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ±â´Éº° Àü¸Á: ¼¼°èÀÇ ÇコÄɾî ERP ½ÃÀå
  • Àç°í ¹× ÀÚÀç °ü¸®
  • °ø±Þ¸Á ¹× ¹°·ù°ü¸®
  • ȯÀÚ °ü°è °ü¸®
  • À繫¿Í û±¸
  • ±âŸ

Á¦5Àå ÇコÄɾî ERP ½ÃÀå : Àü°³º° ÃßÁ¤¡¤µ¿Ç⠺м®

  • Àü°³ ½ÃÀå Á¡À¯À², 2023³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • Àü°³º° Àü¸Á: ¼¼°èÀÇ ÇコÄɾî ERP ½ÃÀå
  • ¿ÂÇÁ·¹¹Ì½º
  • Ŭ¶ó¿ìµå

Á¦6Àå ÇコÄɾî ERP ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2023³â ¹× 2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ÃÖÁ¾ ¿ëµµº° Àü¸Á: ¼¼°èÀÇ ÇコÄɾî ERP ½ÃÀå
  • º´¿ø
  • Ŭ¸®´Ð
  • ±âŸ

Á¦7Àå ÇコÄɾî ERP ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®, ±â´Éº°, Àü°³º°, ÃÖÁ¾ ¿ëµµº°

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • ¼¼°è Áö¿ª ½ÃÀå ÇöȲ
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®(2018-2030³â):
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±ÙÀÇ µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷/°æÀïÀÇ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • McKesson Corporation
    • Oracle
    • SAP SE
    • Microsoft
    • Aptean
    • Odoo
    • Infor
    • Epicor Software Corporation
    • SAGE Group PLC
    • QAD Inc
JHS 24.09.24

Healthcare ERP Market Growth & Trends:

The global healthcare ERP market size is expected to reach USD 11.96 billion by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Healthcare organizations are under pressure to adopt technological solutions to curb rising expenditures, ineffective hospital service management, a workforce shortage, and a growing patient population. The rising awareness of the benefits associated with adopting ERP systems, such as high-quality care delivery solutions, eliminating back-end manual activities, and minimizing operational expenses, contributes to the market's growth.

The adoption of cloud-based ERP systems is growing among healthcare providers due to their inherent advantages. These systems are scalable, allowing organizations to adjust resources as needed without significant investments in hardware. In addition, cloud-based ERP systems provide remote access to data and applications, which is essential for supporting telehealth services and distributed healthcare operations. This access ensures seamless collaboration and continuity of care, even in remote settings.

ERP systems play a crucial role in achieving operational efficiency goals by streamlining processes and reducing redundancies. By integrating various functions such as patient management, inventory control, and financial operations into a single system, ERPs help in eliminating duplicate efforts and ensuring data consistency. They also optimize resource utilization by providing real-time data and analytics, enabling better decision-making and more efficient allocation of staff and materials. This comprehensive approach leads to cost savings and enhanced productivity, ultimately improving patient care and organizational performance.

Market players are focusing on the development of new products and introducing new technologies to reduce the implementation time of ERP systems for their customers. For instance, in January 2024, Atrium Health reduced ERP implementation time by 90% through their newly developed Premier's technology. Premier's item master cleanse, and PINC AI Content Hub streamlined the consolidation of supply chain data, ensuring clean and standardized information. This efficient data management minimized delays, enhanced patient safety, and improved overall operational efficiency, allowing Atrium Health to successfully transition to a new ERP system and optimize resource utilization by providing real-time data and analytics, enabling better decision-making and more efficient allocation of staff and materials. This comprehensive approach leads to cost savings and enhanced productivity, ultimately improving patient care and organizational performance.

Healthcare ERP Market Report Highlights:

  • Based on function segment, finance, and billing dominated the market in 2023, owing to the need to lower barriers between front-end revenue cycle management processes and back-end activities.
  • Based on deployment, the on-premises deployment segment dominated the market in 2023 owing to ease-of-access and minimum maintenance cost of these ERP solutions.
  • Based on end use, the hospital segment dominated the market in 2023. The growth is attributed to the growing need for efficient patient and doctor management tools that reduce paperwork, improve efficacy, and enhance patient care while controlling budget expenses.
  • North America dominated in 2023 due to the rise in adoption levels of these advanced technological systems and the significant presence of market players. Moreover, the Asia Pacific region is anticipated to witness the fastest CAGR of 8.6% from 2024 to 2030.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Function
    • 1.1.2. Deployment
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Function outlook
    • 2.2.2. Deployment outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Healthcare ERP Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Healthcare ERP Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. Case Studies
    • 3.3.4. COVID-19 Impact

Chapter 4. Healthcare ERP Market: Function Estimates & Trend Analysis

  • 4.1. Function Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Healthcare ERP Market by Function Outlook
  • 4.4. Inventory and Material Management
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Supply Chain and Logistics Management
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Patient Relationship Management
    • 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Finance and Billing
    • 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Healthcare ERP Market: Deployment Estimates & Trend Analysis

  • 5.1. Deployment Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Healthcare ERP Market by Deployment Outlook
  • 5.4. On-Premises
    • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Cloud
    • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Healthcare ERP Market: End Use Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Healthcare ERP Market by Application Outlook
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5. Clinics
    • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Healthcare ERP Market: Regional Estimates & Trend Analysis, By Function, By Deployment, By End Use

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/ reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. McKesson Corporation
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Technology Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Oracle
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Technology Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. SAP SE
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Technology Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Microsoft
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Technology Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Aptean
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Technology Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Odoo
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Technology Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Infor
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Technology Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Epicor Software Corporation
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Technology Type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. SAGE Group PLC
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Technology Type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. QAD Inc
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Technology Type benchmarking
      • 8.4.10.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦